Effect of vitamin E on human aortic endothelial cell responses to oxidative injury

Free Radical Biology and Medicine

Volumn 21, Issue 4, 1996, Pages 505-511

  Martin, Antonio ^a,c   Wu, Dayong ^a   Baur, Wendy ^b   Meydani, Simin N ^a   Blumberg, Jeffrey B ^a   Meydani, Mohsen ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

free radicals; Human aortic endothelial cells; Interleukin (IL 1); Oxidative injury; Prostacyclin (PGI2); vitamin E

Indexed keywords

ALPHA TOCOPHEROL; FREE RADICAL;

ARTICLE; ATHEROSCLEROSIS; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0029789143     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)00118-9     Document Type: Article

References (53)

1. 1. DiCorleto, P. E.; Chisolm, G. M. Participation of the endothelium in the development of the atherosclerotic plaque. Prog. Lipid Res. 25:365-374; 1986.
2. 2. Ryan, U. S. Endothelium as transducing surface. J. Mol Cell Cardiol. 21(suppl. I):85-90; 1989.
3. 3. Giulivi, C.; Hochstein, P.; Davies, K. J. A. Hydrogen peroxide production by red blood cells. Free Radic. Biol. Med. 16:123-129; 1994.
4. 4. Weiss, S. J. Tissue destruction by neutrophils. N. Engl. J. Med. 320:365-376; 1989.
5. 5. Steinbrecher, U. P. Role of superoxide in endothelial-cell modification of low density lipoproteins. Biochim. Biophys. Acta 959:20-30; 1988.
6. 6. Martin, A.; Zulueta, J.; Hassoun, M.; Blumberg, J.; Meydani, M. Effect of vitamin E on hydrogen peroxide production by human vascular endothelial cells after hypoxia/reoxygenation. Free Radic. Biol. Med. 20:99-105; 1996.
7. 7. Phillips, P.; Tsan, M. Hyperoxia causes increased albumin permeability of cultured endothelial monolayers. J. Appl. Physiol. 64:1196-1202; 1988.
8. 8. Mugge, A.; Brandes, R.; Boger, R.; Dwenger, A.; Bode-Boger, S.; Kienke, S.; Frolich, J.; Lichtlen, P. Vascular release of superoxide radicals is enhanced in hpercholesterolmic rabbits. J. Cardiovas. Pharmacol. 24:994-998; 1994.
9. 9. Rubbo, H.; Radi, R.; Trujillo, M.; Telleri, R.; Kalyanaraman, B.; Barnes, S.; Kirk, M.; Freeman, B. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 269:26066-75; 1994.
10. 10. Akeson, A.; Woods, C.; Mosher, L.; Thomas, C.; Jackson, R. Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol. Atherosclerosis 86:261-270; 1991.
11. 11. Bevilacqua, M. P.; Pober, J. S.; Wheeler, M. E.; Cotran, R. S.; Gimbrone, M. A. J. Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J. Clin. Invest. 76:2003-2011; 1985.
12. 12. Huang, N.; Lineberger, B.; Steiner, M. Alpha-tocopherol, a potent modulator of endothelial cell function. Thromb. Res. 50:547-557; 1988.
13. 13. Simpson, P. J.; Mitsos, S. E.; Ventura, A.; Gallagher, K. P.; Fantone, J. C.; Abrams, G. D.; Schork, M. A.; Lucchesi, B. R. Prostacyclin protects ischemie reperfused myocardium in the dog by inhibition of neutrophil activation. Am. Heart J. 113:129-137; 1987.
14. 14. Frangos, J. A.; Skin, S. G.; McIntire, L. V.; Ives, C. L. Flow effects on prostacyclin production by cultured human endothelial cells. Science 227:1477-1479; 1985.
15. 15. Stampfer, M. J.; Hennekens, C. H.; Manson, J. E.; Colditz, G. A.; Rosner, B.; Willet, W. C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:1444-1449; 1993.
16. 16. Hennig, B.; Boissonneault, G.; Wang, Y. Protective effects of vitamin E in age-related endothelial cell injury. Int. J. Vit. Nutr. Res. 59:273-279; 1989.
17. 17. Machlin, L. J.; Bendich, A. Free radical tissue damage: Protective role of antioxidant nutrients. FASEB J. 1:444-445; 1987.
18. 18. Patel, J.; Sekharam, M.; Block, E, Vitamin E distribution and modulation of the physical state and function of pulmonary endothelial cell membranes. Exp. Lung Res. 17:707-723; 1991.
19. 19. Smith, W. L.; Marnett, L. J. Prostaglandin endoperoxide synthease: structure and catalysis. Biochim. Biophys. Acta 1083:1-17; 1991.
20. 20. Cannon, J.; Meydani, S.; Fielding, R.; Fiatarone, M.; Meydani, M.; Farhangmehr, M.; Orencole, S.; Blumberg, J.; Evans, W. Acute phase response in exercise. II. Associations between vitamin E, cytokines, and muscle proteolysis. Am. J. Physiol. 260:R1235-R1240; 1991.
21. 21. Verlangieri, A.; Bush, M. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J. Am. Coll. Nutr. 11:131-138; 1992.
22. 22. Carew, T. E.; Schwenke, D. C.; Steinberg, D. Antiatherogenic effects of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidant in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Wantanabe heritable hyperlipidemic (WHHL) rabbit. Proc. Natl. Acad. Sci. USA 84:7725-7729; 1987.
23. 23. Bjorkhem, I.; Henricksson-Freyschuss, A.; Breuer, O.; Diczfalusy, U.; Berglund, L.; Henricksson, P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Atherioscler. Thromb. 11:15-22; 1991.
24. 24. Parker, R. A.; Sabrah, T.; Cap, M.; Gill, B. T, Relation of vascular oxidative stress, α-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler. Thromb. Vasc. Biol. 15:349-358; 1995.
25. 25. Bendich, A.; Machlin, L. J. Safety of oral intake of vitamin E. Am. J. Clin. Nutr. 48:612-619; 1988.
26. 26. Meydani, S. N.; Barklund, P. M.; Liu, S.; Meydani, M.; Miller, R.; Cannon, J.; Morrow, F.; Rocklin, R.; Blumberg, J. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am. J. Clin. Nutr. 52:557-563; 1990.
27. 27. Hodis, H.; Mack, W.; LaBree, L.; Cashin-Hemphill, L.; Sevanian, A.; Johnson, R.; Azen, S. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273:1849-1854; 1995.
28. 28. Dooley, M. M.; Sano, N.; Kawashima, H.; Nakamura, T. Effects of 2,2′-azobis (2-amidinopropane) hydrochloride in vivo and protection by vitamin E. Free Radic. Biol. Med. 9:199-204; 1990.
29. 29. Jaffee, E. A.; Hoyer, L. W.; Nachman, R. L. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc. Natl. Acad. Sci. USA 71:1906-1913; 1974.
30. 30. McCosh, E.; Meyer, D. L.; Dupont, J. Radioimmunoassay of prostaglandins E1, E2 and F2 α in unextracted plasma, serum, and myocardium. Prostaglandins 12:472-486; 1976.
31. 31. Endres, S.; Ghorbani, R.; Lonnemann, G.; Van der Meer, J.; Dinarello, C. Measurement of immunoreactive interleukin-1β for human mononuclear cells: Optimization of recovery, intrasubject consistency and comparison with interleukin-1α and tumor necrosis factor. Clin. Immunol. Immunopathol. 49:424-438; 1988.
32. 32. Meydani, M.; Chon, J. S.; Macauley, J. B.; McNamara, J. R.; Blumberg, J. B.; Schaefer, E. J. Postprandial changes in the plasma concentration of α-and γ-tocopherol in human subjects fed fat-rich meal supplemented with fat-soluble vitamins. J. Nutr. 119:1252-1258; 1989.
33. 33. Kaneko, T.; Nakano. S.; Matsuo, M. Protective effect of vitamin E on linoleic acid hydroperoxide-induced injury to human endothelial cells. Lipids 26:345-348; 1991.
34. 34. Janero, D. R.; Burghardt, B. Oxidative injury to myocardial membrane: Direct modulation by endogenous alpha-tocopherol. J. Mol. Cell Cardiovasc. 21:1111-1124; 1989.
35. 35. Boscoboinik, D.; Szewczyk, A.; Hensey, C.; Azzi, A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein Kinase C. J. Biol. Chem. 266:6188-6194; 1991.
36. 36. Joiner, W. L.; Strand, J. C. Differential release of prostaglandin E-like and F-like substances by endothelial cells cultured from human umbilical arteries and veins. Microsc. Res. 16:119-122; 1978.
37. 37. Vanhoutte, P. M. The end of quest? Nature 327:459-460; 1987.
38. 38. Boxer, L. A.; Allen, J. M.; Schmidt, M.; Yoder, M.; Baehner, R. L. Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J. Lab. Clin. Med. 95:672-678; 1980.
39. 39. FitzGerald, G. A.; Friedman, L. A.; Miyamori, I.; O'Grady, J. O.; Lewis, P. J. A double blind placebo controlled crossover study of prostacyclin in man. Life Sci. 25:665-672; 1979.
40. 40. Voss, R.; Ten Hoor, F.; Matthias, F. R. Prostacyclin production and atherosclerosis of the rabbit aorta. Adv. Prostaglandin Thromboxane Leukot. Res. 11:469-474; 1983.
41. 41. Weksler, B. B.; Ley, C. W.; Jaffe, E. A. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the inophore A 23187. J. Clin. Invest. 62:923-930; 1978.
42. 42. Grabowski, E. F.; Jaffe, E. A.; Weksler, B. B. Prostacyclin production by cultured endothelial cell monolayers exposed to step increase in shear stress. J. Lab. Clin. Med. 105:36-43; 1985.
43. 43. Bermylen, J.; Chamone, D. A.; Verstraete, M. Stimulation of prostacyclin release from vessel wall by Bay g 6575, an anti-thrombotic compound. Lancet i:518-520; 1979.
44. 44. Spector, A. A.; Scanu, A. M.; Kaduce, T. L.; Figard, P. H.; Fless, G. M.; Czervionke, R. L. Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells, J. Lipid Res. 26:288-297; 1985.
45. 45. Triau, J. E.; Meydani, S. N.; Schaefer, E. J. Oxidized low density lipoprotein stimulates prostacyclin production by adult human vascular endothelial cells. Arteriosclerosis 8:810-818; 1988.
46. 46. Dinarello, C. A. Biology of interleukine-1. FASEB J. 2:108-115; 1989.
47. 47. Pober, J. S.; Cotran, R. S. The role of endothelial cells in inflammation. Transplantation 50:537-542; 1990.
48. 48. Dinarello, C. H. Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44:153-205; 1989.
49. 49. Faruqi, R. M.; DiCorleto, P. E. Mechanisms of monocytes recruitment and accumulation. Br. Heart J. 69:S19-S29; 1993.
50. 50. Akeson, A.; Mosher, L.; Woods, C.; Schroeder, K.; Bowlin, T. Human aorta endothelial cells express the type I but not the type II receptor for interleukin-1 (IL-1). J. Cell. Physiol. 153:583-588; 1992.
51. 51. Kuijpers, T.; Hakkert, B.; Hoogerwerf, M.; Leeuwenberg, J.; Roos, D. Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1 prestimulated endothelial cells. Endothelial leukocyte adhesion molecule-1-mediated CD18 activation. J. Immunol. 147:1369-1376; 1991.
52. 52. Knudsen, P.; Dinarello, C.; Strom, T. Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cyclic adenosine monophosphate. J. Immunol. 37:3189-3194; 1986.
53. 53. Frostegard, J.; Haegerstrand, A.; Gidlund, M.; Nilsson, J. Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 90: 119-126; 1991.